Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Prina

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|December 25, 2013
Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infectionNajma Rachidi, Jean François Taly, Emilie Durieu, et al.
Structure (London, England : 1993)|August 14, 2012
The crystal structure of the MAP kinase LmaMPK10 from Leishmania major reveals parasite-specific features and regulatory mechanismsSofía Horjales, Dirk Schmidt-Arras, Ramiro Rodriguez Limardo, et al.
Communications Biology|November 15, 2022
Trifloxystrobin blocks the growth of Theileria parasites and is a promising drug to treat Buparvaquone resistanceMarie Villares, Nelly Lourenço, Jeremy Berthelet, et al.
Microbes and Infection|September 30, 2009
Sorting of Leishmania-bearing dendritic cells reveals subtle parasite-induced modulation of host-cell gene expressionHervé Lecoeur, Emilie de La Llave, José Osorio Y Fortéa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 17, 2022
Targeting chalcone binding sites in living Leishmania using a reversible fluorogenic benzochalcone probeAriane S Batista, Suellen D S Oliveira, Sébastien Pomel, et al.
Plos Neglected Tropical Diseases|April 18, 2013
High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discoveryNathalie Aulner, Anne Danckaert, Eline Rouault-Hardoin, et al.
Frontiers in Immunology|June 26, 2020
<i>Leishmania amazonensis</i> Subverts the Transcription Factor Landscape in Dendritic Cells to Avoid Inflammasome Activation and Stall MaturationHervé Lecoeur, Thibault Rosazza, Kossiwa Kokou, et al.
Cell Reports|February 13, 2020
Targeting Macrophage Histone H3 Modification as a Leishmania Strategy to Dampen the NF-κB/NLRP3-Mediated Inflammatory ResponseHervé Lecoeur, Eric Prina, Thibault Rosazza, et al.
Vaccines|October 17, 2019
The Immunomodulatory Effect of IrSPI, a Tick Salivary Gland Serine Protease Inhibitor Involved in <i>Ixodes ricinus</i> Tick FeedingAdrien A Blisnick, Ladislav Šimo, Catherine Grillon, et al.
International Journal for Parasitology. Drugs and Drug Resistance|January 21, 2017
Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growthMing Jang Chua, Megan S J Arnold, Weijun Xu, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|December 25, 2013
Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infectionNajma Rachidi, Jean François Taly, Emilie Durieu, et al.
Structure (London, England : 1993)|August 14, 2012
The crystal structure of the MAP kinase LmaMPK10 from Leishmania major reveals parasite-specific features and regulatory mechanismsSofía Horjales, Dirk Schmidt-Arras, Ramiro Rodriguez Limardo, et al.
Communications Biology|November 15, 2022
Trifloxystrobin blocks the growth of Theileria parasites and is a promising drug to treat Buparvaquone resistanceMarie Villares, Nelly Lourenço, Jeremy Berthelet, et al.
Microbes and Infection|September 30, 2009
Sorting of Leishmania-bearing dendritic cells reveals subtle parasite-induced modulation of host-cell gene expressionHervé Lecoeur, Emilie de La Llave, José Osorio Y Fortéa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 17, 2022
Targeting chalcone binding sites in living Leishmania using a reversible fluorogenic benzochalcone probeAriane S Batista, Suellen D S Oliveira, Sébastien Pomel, et al.
Plos Neglected Tropical Diseases|April 18, 2013
High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discoveryNathalie Aulner, Anne Danckaert, Eline Rouault-Hardoin, et al.
Frontiers in Immunology|June 26, 2020
<i>Leishmania amazonensis</i> Subverts the Transcription Factor Landscape in Dendritic Cells to Avoid Inflammasome Activation and Stall MaturationHervé Lecoeur, Thibault Rosazza, Kossiwa Kokou, et al.
Cell Reports|February 13, 2020
Targeting Macrophage Histone H3 Modification as a Leishmania Strategy to Dampen the NF-κB/NLRP3-Mediated Inflammatory ResponseHervé Lecoeur, Eric Prina, Thibault Rosazza, et al.
Vaccines|October 17, 2019
The Immunomodulatory Effect of IrSPI, a Tick Salivary Gland Serine Protease Inhibitor Involved in <i>Ixodes ricinus</i> Tick FeedingAdrien A Blisnick, Ladislav Šimo, Catherine Grillon, et al.
International Journal for Parasitology. Drugs and Drug Resistance|January 21, 2017
Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growthMing Jang Chua, Megan S J Arnold, Weijun Xu, et al.
Pageof 5